So-called 'functional cure' to HIV makes way into human trials

By REUTERS
December 1, 2016 07:26

A surprising study in monkeys involving an antibody used to treat Crohn's disease has raised new hopes for a so-called "functional cure" for HIV - treatments that put their disease in sustained remission - allowing patients to skip the daily cocktail of pills they must take to keep their disease in check.

The study came out of the lab of Dr. Anthony Fauci, director of the National Institutes of Allergy and Infectious Disease in Bethesda, who is now presiding over a clinical trial testing whether the drug, made by Japanese drug maker Takeda, can control HIV without the need for ongoing treatment.


Related Content

Breaking news
September 18, 2019
Joint List leader Odeh: ‘Abu-Yair, incitement has a price’

By JERUSALEM POST STAFF